Compare TARA & TII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TARA | TII |
|---|---|---|
| Founded | N/A | 2012 |
| Country | United States | Canada |
| Employees | N/A | 167 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.8M | 232.9M |
| IPO Year | 2014 | N/A |
| Metric | TARA | TII |
|---|---|---|
| Price | $4.34 | $2.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $24.40 | $6.38 |
| AVG Volume (30 Days) | ★ 766.5K | 295.9K |
| Earning Date | 05-01-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.25 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,948,000.00 | N/A |
| Revenue This Year | N/A | $4.20 |
| Revenue Next Year | N/A | $3.46 |
| P/E Ratio | ★ N/A | $25.66 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.77 | $2.07 |
| 52 Week High | $7.82 | $5.65 |
| Indicator | TARA | TII |
|---|---|---|
| Relative Strength Index (RSI) | 34.51 | 45.45 |
| Support Level | $4.21 | $2.09 |
| Resistance Level | $4.59 | $3.14 |
| Average True Range (ATR) | 0.30 | 0.19 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 4.29 | 30.43 |
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.
Titan Mining Corp is a Canadian natural resources company. The company is engaged in the acquisition, exploration, development, and extraction of mineral properties. The company owns an interest in the Empire State Mine in Northern New York State, United States, and Kilbourne Graphite Project. The Company operates one reportable segment, mineral production and exploration in the United States.